P591: Examining likely-somatic variants in cancer susceptibility genes identified through germline multigene panel testing

• Kate Loranger,
• Jingwen Zhang,
• Urmi Sengupta,
• Jeffrey Weitzel,
• Mia Mackall,
• Youbao Sha

Affiliations

Kate Loranger

Natera, Inc.

Jingwen Zhang

Natera, Inc.

Urmi Sengupta

Natera, Inc.

Jeffrey Weitzel

Natera, Inc., The University of Kansas Cancer Center

Mia Mackall

Natera, Inc.

Youbao Sha

Natera, Inc.